EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ZILBRYSQ was filed as Word mark on 03/27/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/28/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018217277 |
| Application date | March 27, 2020 |
| Publication date | April 17, 2020 |
| Entry date | July 28, 2020 |
| Expiration date | March 27, 2030 |
Trademark owner
87 Cambridge Park Drive
02140 Cambridge
US
02140 Cambridge
US
Trademark representatives
Drakestr. 58
12205 Berlin
DE
goods and services
5
Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents
10
Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 14, 2021 | Change Representative, Published |
ID: 11018217277